We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$412M
AUM Growth
-$24.9M
Cap. Flow
-$20.3M
Cap. Flow %
-4.93%
Top 10 Hldgs %
62.81%
Holding
32
New
1
Increased
17
Reduced
13
Closed
1

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$15.5M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$11.3M
3
CI icon
Cigna
CI
+$7.37M
4
BSX icon
Boston Scientific
BSX
+$6.24M
5
ELV icon
Elevance Health
ELV
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
26
Acadia Pharmaceuticals
ACAD
$4.35B
$4.38M 1.06%
232,718
+46,883
+25% +$893K
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$2.65B
$4.26M 1.03%
106,282
+60,762
+133% +$2.61M
VIR icon
28
Vir Biotechnology
VIR
$1.48B
$3.39M 0.82%
145,545
+55,737
+62% +$1.43M
BNTX icon
29
BioNTech
BNTX
$23B
$3.31M 0.8%
26,554
+2,816
+12% +$387K
CVS icon
30
CVS Health
CVS
$137B
$2.85M 0.69%
38,310
-5,133
-12% -$430K
PTCT icon
31
PTC Therapeutics
PTCT
$6.29B
$2.66M 0.64%
54,906
-31,786
-37% -$1.45M
CI icon
32
Cigna
CI
$77B
-22,252
Closed -$7.37M

Similar funds

Sector Gamma AS's Q1 2023 Portfolio in Review

As of Q1 2023, Sector Gamma AS held 32 positions worth $412M, down 5.7% from $437M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $20.3M in Q1 2023, closing 1 position and reducing 13 holdings. Its most notable exit was Cigna, an estimated $7.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Alnylam Pharmaceuticals worth $5.49M.

  • Sector Gamma AS's largest Q1 2023 buy was Alnylam Pharmaceuticals: 27,389 shares worth $5.49M.
  • Sector Gamma AS added most to CATALENT, INC. in Q1 2023, an estimated $5.9M increase.
  • Sector Gamma AS's biggest Q1 2023 reduction was Merck, cutting an estimated $15.5M.
  • Sector Gamma AS fully exited Cigna in Q1 2023, selling an estimated $7.37M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $412M portfolio in Q1 2023.
  • Sector Gamma AS opened 1 new position and closed 1 in Q1 2023.
  • Sector Gamma AS's portfolio value fell 5.7% quarter-over-quarter to $412M.

Based on Sector Gamma AS's 13F filing for Q1 2023, filed 12 May 2023.